Therapeutic vaccines in HBV: lessons from HCV
Currently, millions of people infected with hepatitis B virus (HBV) are committed to decades of treatment with anti-viral therapy to control viral replication. However, new tools for immunotherapy that include both viral vectors and molecular checkpoint inhibitors are now available. This has led to...
| Autor Principal: | |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado: |
Springer Berlin Heidelberg
2015
|